Published in Nat Commun on April 24, 2017
Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods (2009) 18.51
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol (2004) 7.69
Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol (2005) 4.75
Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation. Nat Cell Biol (2011) 4.59
The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol (2011) 4.24
Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res (2007) 3.30
The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell (2005) 2.91
Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell (2011) 2.77
Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia. J Cell Biol (2010) 2.62
Substrate stiffness regulates cadherin-dependent collective migration through myosin-II contractility. J Cell Biol (2012) 2.33
Extracellular matrix rigidity promotes invadopodia activity. Curr Biol (2008) 2.31
The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion. Curr Biol (2010) 2.23
Actin machinery and mechanosensitivity in invadopodia, podosomes and focal adhesions. J Cell Sci (2009) 2.13
Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nat Genet (2007) 1.98
Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts. Cancer Res (2002) 1.96
Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp Cell Res (2006) 1.96
Global impact of oncogenic Src on a phosphotyrosine proteome. J Proteome Res (2008) 1.94
Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev (2009) 1.85
N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J Cell Sci (2012) 1.84
ShcA signalling is essential for tumour progression in mouse models of human breast cancer. EMBO J (2008) 1.82
Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion. J Cell Biol (2008) 1.79
An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. Cancer Res (2011) 1.75
Ultrastructural localization of alpha-actinin and filamin in cultured cells with the immunogold staining (IGS) method. J Cell Biol (1984) 1.63
Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. Cancer Res (2010) 1.62
Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK-p130Cas complex. J Cell Biol (2012) 1.59
Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins. Cell Motil Cytoskeleton (2001) 1.55
How to calculate sample size in animal studies? J Pharmacol Pharmacother (2013) 1.50
Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomics. Mol Cell Proteomics (2008) 1.46
Hic-5 promotes invadopodia formation and invasion during TGF-β-induced epithelial-mesenchymal transition. J Cell Biol (2012) 1.45
Distribution of alpha-actinin in single isolated smooth muscle cells. J Cell Biol (1983) 1.29
Adhesion rings surround invadopodia and promote maturation. Biol Open (2012) 1.23
Multiparametric classification links tumor microenvironments with tumor cell phenotype. PLoS Biol (2014) 1.22
Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis. Cell Rep (2014) 1.22
TGFbeta-induced endothelial podosomes mediate basement membrane collagen degradation in arterial vessels. J Cell Sci (2009) 1.20
Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis. Sci Signal (2012) 1.19
Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion. Mol Cell Biol (2008) 1.14
Invading one step at a time: the role of invadopodia in tumor metastasis. Oncogene (2013) 1.13
Genetic and pharmacologic inhibition of eIF4E reduces breast cancer cell migration, invasion, and metastasis. Cancer Res (2015) 1.12
Targeting invadopodia to block breast cancer metastasis. Oncotarget (2011) 1.10
Sensing and modulation of invadopodia across a wide range of rigidities. Biophys J (2011) 1.05
Cell Adhesion and Transcriptional Activity - Defining the Role of the Novel Protooncogene LPP. Transl Oncol (2009) 1.05
Mammary epithelial-specific disruption of c-Src impairs cell cycle progression and tumorigenesis. Proc Natl Acad Sci U S A (2011) 1.03
Pathological roles of invadopodia in cancer invasion and metastasis. Eur J Cell Biol (2012) 1.01
Digging a little deeper: the stages of invadopodium formation and maturation. Eur J Cell Biol (2014) 1.00
Met receptor tyrosine kinase signals through a cortactin-Gab1 scaffold complex, to mediate invadopodia. J Cell Sci (2012) 0.98
Integrin-matrix clusters form podosome-like adhesions in the absence of traction forces. Cell Rep (2013) 0.98
Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events. J Proteome Res (2010) 0.97
TGF-beta induces formation of F-actin cores and matrix degradation in human breast cancer cells via distinct signaling pathways. Exp Cell Res (2008) 0.94
High-resolution live-cell imaging and time-lapse microscopy of invadopodium dynamics and tracking analysis. Methods Mol Biol (2013) 0.91
Identification of targets of c-Src tyrosine kinase by chemical complementation and phosphoproteomics. Mol Cell Proteomics (2012) 0.90
Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo. Breast Cancer Res (2012) 0.90
A complex containing LPP and α-actinin mediates TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells. J Cell Sci (2013) 0.89
Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis. Oncotarget (2015) 0.86
Soft matrix is a natural stimulator for cellular invasiveness. Mol Biol Cell (2013) 0.86
PTP1B promotes cell proliferation and metastasis through activating src and ERK1/2 in non-small cell lung cancer. Cancer Lett (2015) 0.85
Biphasic response of cell invasion to matrix stiffness in three-dimensional biopolymer networks. Acta Biomater (2014) 0.85
Invadopodia in context. Cell Adh Migr (2014) 0.84
The interplay between the proteolytic, invasive, and adhesive domains of invadopodia and their roles in cancer invasion. Cell Adh Migr (2014) 0.83
Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis. J Biol Chem (2012) 0.82
Organizing motility: LIM domains, LPP, and smooth muscle migration. Circ Res (2006) 0.81
The invadopodia scaffold protein Tks5 is required for the growth of human breast cancer cells in vitro and in vivo. PLoS One (2015) 0.81
Invadopodia: a new therapeutic target to block cancer metastasis. Expert Rev Anticancer Ther (2015) 0.80
Modulation of stretch-induced myocyte remodeling and gene expression by nitric oxide: a novel role for lipoma preferred partner in myofibrillogenesis. Am J Physiol Heart Circ Physiol (2013) 0.79
Regulation of invadopodia by mechanical signaling. Exp Cell Res (2015) 0.78
Podosomes and invadopodia: tools to breach vascular basement membrane. Cell Cycle (2015) 0.78
Extravasation during bladder cancer metastasis requires cortactin‑mediated invadopodia formation. Mol Med Rep (2014) 0.77
Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models. EMBO Mol Med (2017) 0.75
Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature. Nanoscale (2017) 0.75
Response to Alternating Electric Fields of Tubulin Dimers and Microtubule Ensembles in Electrolytic Solutions. Sci Rep (2017) 0.75